BioBehavioral Nabs $10M

Luke Timmerman2/1/10

BioBehavioral Diagnostics, the Westford, MA-based maker of a tool for diagnosing attention-deficit hyperactivity disorder, said today it has raised $10 million in a Series B financing. Sevin Rosen Funds and Tullis Dickerson led the round, according to the company. BioBehavioral plans to use the cash to expand its sales and marketing efforts, and do more clinical work for its Quotient ADHD System.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.